Background and Objectives Obstetric haemorrhage is associated with increased blood transfusion, morbidity and health service usage in women. While the use of transfusion in actively bleeding patients is supported, there is little evidence for the use of blood as treatment in the nonbleeding patient following obstetric haemorrhage. Transfusion may expose women to increased morbidity. This study aims to compare outcomes between low-risk women receiving no or 1-2 units of blood in the context of obstetric haemorrhage.
Introduction
Excessive bleeding around the time of childbirth (including antepartum, intrapartum and postpartum haemorrhage, termed obstetric haemorrhage) is associated with increased morbidity and longer hospital stays compared to women without haemorrhage. Rates of postpartum haemorrhage (5-15% of births) [1] , the main contributor to obstetric haemorrhage, are increasing in the United States, Canada, Australia and elsewhere [2] [3] [4] [5] . Rates of red blood cell (RBC) transfusion in pregnancy and postpartum range from 0Á1 to 2% [6, 7] ; however, these have also been increasing [8] . There is little evidence guiding transfusion in obstetric patients, with current guidelines based around expert opinion and trials in nonpregnant patients [9] .
There is growing concern that transfused patients have poorer outcomes compared with similar patients not receiving transfusions. Observational studies and randomised trials have found transfusion to be associated with adverse outcomes including increased mortality, wound infection, sepsis, pneumonia, organ failure and mechanical ventilation [10] [11] [12] [13] [14] [15] . However, a Cochrane review of randomised trials comparing liberal and restrictive transfusion strategies reports no difference in mortality and morbidity [16] . These findings, in combination with concerns about the decreasing donor base [17] and increasing costs of supplying blood [17] , have led to calls to reduce transfusion, including in obstetrics. It is not clear to what extent findings of studies conducted in surgical, critical care and cardiac patients apply to the generally younger and otherwise healthy obstetric population.
While large volume transfusions reflect management of a massive haemorrhage, small volume transfusions may reflect discretionary transfusions used to treat anaemia and/or symptoms that may be managed conservatively without resorting to blood products. Postpartum anaemia is associated with fatigue, postnatal depression [18, 19] , lower rates of breastfeeding [20] , impaired cognition [21] and poorer maternal-infant bonding [22] . Although transfusion is a common treatment for postpartum anaemia, there is little evidence to support this practice. One trial of restrictive transfusion strategies in obstetric patients, found no clinically relevant difference in fatigue between those transfused and women assigned to nonintervention, and no difference in infection complications and breastfeeding [23] . Current guidelines support the use of transfusion in the actively bleeding obstetric patient and a restrictive approach to transfusion otherwise [9, 24] ; however, the benefits and risks of transfusion following obstetric haemorrhage are largely unknown [9] . Routinely collected administrative data can be used to examine outcomes associated with transfusion; however, hospital data usually do not contain detail on number of packs transfused. Linkage to blood issue data provided us an opportunity to examine outcomes following small volume transfusions. This study aimed to compare health and health service utilisation outcomes between low-risk nontransfused women and those receiving 1-2 units of blood in the context of obstetric haemorrhage.
Methods

Study population and data collection
The study population included all low-risk women giving birth to a singleton infant at term in New South Wales (NSW) hospitals between July 2006 and December 2010, where a diagnosis of obstetric haemorrhage (including antenatal, intrapartum and postpartum haemorrhage) was recorded in hospitalisation data. Postpartum haemorrhage is defined as blood loss of >500 ml following vaginal birth and >750 ml following Caesarean section. The study population was limited to women receiving no or 1-2 transfusions of RBC, to minimise confounding by indication (i.e. poor outcomes because of the reason or 'indication' for the massive transfusion, as opposed to the transfusion itself). Ideally, the study population would have further been restricted to women with anaemia without evidence of active bleeding; however, anaemia and timing of bleeding are not well collected. Women with a hospital diagnosis of placental abruption, placenta praevia, morbidly adherent placenta, bleeding or platelet disorders, hypertension, diabetes, other chronic conditions and those who required a transfusion during pregnancy were considered high risk of adverse outcomes and so excluded. Women receiving other blood products (including platelets and fresh frozen plasma) in addition to RBC were also excluded, as this generally indicates management of a more severe haemorrhage.
This was a retrospective observational study using routinely collected data. Data on maternal characteristics and pregnancy history were obtained from the Perinatal Data Collection, and data on medical diagnoses and procedures, including transfusion, from the Admitted Patients Data Collection. The Perinatal Data Collection is a statutory collection of pregnancy and birth information on all livebirths and stillbirths of at least 400g birthweight or 20 weeks of gestation in NSW. The Admitted Patients Data Collection contains data on all NSW hospital admissions and includes diagnoses coded according to the International Statistical Classification of Diseases 10th RevisionAustralian Modification, and procedures coded according to the Australian Classification of Health Interventions. Data on number of transfusions received and associated pathology tests were obtained from the NSW Clinical Excellence Commission 'BloodWatch' Red Cell Utilisation database, and from the Red Cross Blood Bank databases ('Red cell data'). The Red Cell Utilisation database records information on each red cell unit issued to patients in NSW public hospitals; however, data were not available for all hospitals for the whole time period. Haemoglobin testing information was available in this database for some women. The Red Cross Blood Bank database contains information on each unit of RBC distributed to NSW hospitals. Registry of Births, Deaths and Marriages data were used to identify out of hospital deaths.
The Centre for Health Record Linkage (CHeReL) undertook probabilistic linkage to link the databases based on personal identifiers [25] . Deidentified data were provided to the researchers. Red cell data were used to identify women with obstetric haemorrhage who received a transfusion of 1-2 units of blood during the hospital admission in which they gave birth; all women birthing in that hospital during the same month who experienced obstetric haemorrhage but did not receive a transfusion were selected for comparison.
Exposure and outcomes
The exposure of interest was transfusion of 1-2 units of RBC during the birth admission (either prior to or following birth). The primary outcome was severe maternal morbidity, measured by a composite indicator including diagnoses and procedures indicative of severe morbidity (e.g. cerebral oedema or coma, cardiac arrest, acute renal failure, mechanical ventilation for >8 h and dialysis) [26] . Transfusion-related indicators of morbidity, uterine rupture and procedures known to occur postbirth (such as hysterectomy, repair of bladder/intestine) were removed from the original indicator. Secondary outcomes were length of stay >5 days, intensive care unit (ICU) admission, readmission for any reason (within the first 6 weeks), breastfeeding at discharge from the birth admission (any vs. none) and all-cause mortality (at 6 weeks and 12 months). Information on potential confounders (listed in Table 1 ) was obtained from the birth and hospital data, where they are reliably reported. Women were considered at increased PPH risk if they had experienced a PPH or caesarean section in a previous pregnancy. Reason for readmission was determined from the primary diagnosis at readmission.
Pretransfusion haemoglobin was calculated as the minimum haemoglobin recorded on or in the two days prior to the transfusion. Post-transfusion haemoglobin was the maximum haemoglobin in the two days following transfusion. The percentage change in haemoglobin was calculated where both pre-and post-transfusion measures were available.
Statistical analysis
Unadjusted comparisons between transfused and nontransfused women were made using Chi-square tests and relative risks of categorical variables, and the Wilcoxon test for length of stay. To try to isolate the effect of transfusion on adverse outcomes, propensity score matching was used to create two groups of women with similar characteristics and risk factors, who differed on whether they received a transfusion. A logistic regression model was built using the maternal and pregnancy characteristics listed in Table 1 to predict the probability of transfusion. Nearest neighbour propensity score matching with exact matching on hospital type, and a caliper of 0Á1 standard deviations of the logit of the propensity score was then used to find nontransfused women who most closely resembled the transfused women across all characteristics considered. The average standardised absolute mean distance was used as a measure of balance between the two groups. Modified Poisson regression models were then used to determine the relationship between each adverse outcome and transfusion within the matched sample, additionally adjusting for the propensity score [27] .
As haemoglobin results were only available for transfused women, and haemoglobin levels were the only reliable measure of anaemia, it was not possible to adjust for anaemia. To assess the potential effect of anaemia, a LGA, large for gestational age; NVD, normal vaginal delivery, SGA, small for gestational age. *P < 0Á01, **P < 0Á001.
probabilistic bias analysis was performed [28] . Probabilistic bias analysis gives an indication of the expected change in risk associated with transfusion, had we been able to additionally adjust for anaemia. For this analysis, a prevalence of 80% (range 70-90%) for anaemia in transfused women (based on available data) and 30% in nontransfused women (range 5-60%) was used. The rate in nontransfused women was selected to reflect rates reported in other studies, which ranged from 13% [29] to around 50% [30] . The risk of severe morbidity associated with anaemia in a postpartum population is unknown; however, a review by Shander et al. reports relative risks of around 1Á5 to 2Á5 across a range of patient populations [31] , so a relative risk of 2Á5 was used as a conservative estimate (range 1Á2-3Á0).
To address the concern that women receiving blood were a sicker or more anaemic population, a sensitivity analysis was performed comparing women with a pretransfusion haemoglobin ≥70 g/l to nontransfused women.
This study was approved by the NSW Population and Health Services Research Ethics Committee. Analyses were performed in SAS 9Á4 and R 3Á3Á1. Probabilistic bias analysis was conducted in Microsoft Excel.
Results
There were 218 324 births in participating hospitals, of which 165 529 (75Á8%) were to women considered low risk. Among the low-risk women, the obstetric haemorrhage rate was 9Á1% (N = 14 989), and 1702 (1Á1%) were transfused (1-2 units N = 1069, 3+ units N = 633). Ninety-five women received a single unit of blood. Women with obstetric haemorrhage receiving no or 1-2 units of blood were retained for analysis (N = 14 356) (Fig. S1) .
Transfused women were more likely to be primiparous, have an instrumental delivery and give birth outside of a tertiary centre (Table 1) . In unadjusted analysis, transfused women were more likely to experience severe morbidity, ICU admission, organ failure, readmission and longer hospital stays. Their infants were less likely to be receiving any breastmilk on hospital discharge (Table 2) . There were 575 (4%) women readmitted within 6 weeks. The primary reason for readmission in both transfused and nontransfused women was bleeding related (including delayed postpartum haemorrhage and retained placenta), with higher rates amongst transfused women (Table 3) .
The median pretransfusion haemoglobin was 76 g/l (Interquartile range 69, 90, n = 720), and 527 (73%) had a pretransfusion haemoglobin ≥70 g/l. The median posttransfusion haemoglobin was 89 g/l (IQR 83, 96, n = 651). Among the 631 (59%) transfused women with pre-and post-transfusion haemoglobin measures, 387 (61%) experienced an increase in haemoglobin of >10%.
After excluding women with missing data, 14 257 (99Á3%) women were included in the propensity score analysis. One thousand and sixty-five women receiving 1-2 units of RBC were matched to 1065 nontransfused women (Table S1 ). Within the matched sample, transfused women were more likely to experience severe morbidity (Relative risk 7Á0, 95% CI(2Á8, 17Á8)) and to experience long hospital stays (Table 2) . Transfused women were less likely to be breastfeeding on hospital discharge. There were insufficient deaths (<5) available for analysis.
After probabilistic bias analysis to estimate the potential effect of anaemia on the relationship between transfusion and morbidity, the relative risk of severe morbidity was attenuated, but remained significant (RR 5Á0 95% CI (1Á9, 13Á4) ). The results of the sensitivity analysis amongst those transfused having a pretransfusion haemoglobin ≥70 compared with nontransfused women were consistent with the primary analysis, with the transfused group experiencing higher rates of severe morbidity. 
Discussion
Within this population of low-risk women, almost one in 10 had an obstetric haemorrhage, and of those women, one in 10 received a transfusion, with the majority receiving 1-2 units of blood. Among those receiving no transfusion or 1-2 units, serious maternal morbidity was experienced by around 1%, with higher rates experienced by transfused women, even after accounting for differences in patient characteristics. The transfusion rate found in this population is comparable but slightly higher than transfusion rates of 7Á8-9Á5% for PPH reported in other developed countries [5, 32, 33] ; however, differences exist in definition and ascertainment of obstetric haemorrhage between countries [3] .
Unadjusted analyses also showed that health service utilisation was higher in transfused women, with longer hospitalisations for delivery, and higher rates of readmission. Length of stay in transfused women was around 1 day longer than nontransfused women. This finding is different to that of two studies in moderately anaemic parturients where no difference in length of stay was found [23, 34] . This may reflect differences in clinical practice between countries, as in one of these studies, the median length of stay was 5 days [34] , which is longer than both transfused and nontransfused women in this study. In this study, around 4% of nontransfused women were readmitted within 6 weeks of giving birth, which is similar to the rate reported in a systematic review of outcomes following PPH [35] but is approximately double readmission rates reported in the general obstetric population [36, 37] . In accordance with the principles of patient blood management [38] , the ongoing risk of readmission among transfused women could be addressed by strategies to monitor and prevent anaemia during pregnancy and postnatally [30, 39] , including the use of oral iron supplementation or intravenous iron to provide women with greater haemopoietic reserve should they experience bleeding [40, 41] .
After using propensity score analysis to account for differences in patient factors which might predispose certain women to both transfusion and worse outcomes, the strength of the risk of morbidity associated with transfusion was attenuated but not removed. Transfusion was associated with increased rates of severe morbidity, ICU admission, prolonged hospital stay and readmission, as well as reduced breastfeeding rates. The residual effect of transfusion on outcomes after accounting for maternal condition suggests that transfusion of even 1-2 units of blood may convey an increased risk of morbidity, as suggested in other disciplines [13, [42] [43] [44] . The propensity score methods utilised in this study assume that data are available on all relevant confounders [45] , so that differences found between groups can be attributed to the treatment received [27, 45] . A large range of possible confounders was used in this study; however, measures of anaemia were not available for all patients. Anaemia in pregnancy is known to increase risks to both the mother and the baby [40, 41] , and to increase the risk of transfusion. [39] Probabilistic bias analysis was used to estimate the possible range of effects of anaemia on morbidity, and transfusion remained an independent risk factor for severe morbidity.
Recent obstetric and other specialty guidelines suggest that in the absence of active bleeding, transfusion when the haemoglobin is >70 g/l is not associated with improved patient outcomes [9, 40, [46] [47] [48] . Almost threequarters of transfusions in this study were given to women with a pretransfusion haemoglobin >70 g/l; however, it is not known whether this was in the presence of active bleeding. In an audit of obstetric transfusions at a tertiary hospital in the United Kingdom, Parker et al. found that 31% of transfusions were given to women with a haemoglobin >70 g/l in the absence of symptoms or ongoing bleeding [49] . A French study, however, found evidence of undertransfusion, with only half the women with clinically diagnosed PPH and having a haemoglobin <70 g/l receiving a transfusion [32] . In this study, although more than half the women experienced a clinically significant increase in haemoglobin post-transfusion, clinical outcomes following transfusion were not improved. Recent Australian guidelines for patient blood management in obstetric patients, published after the study period, specify that in the absence of active bleeding, nontransfusion therapies should be considered rather than transfusion, depending on the clinical situation [9] .
The strengths of this study include the large number of women included across a variety of hospital types which enabled the detection of rare outcomes, the use of a validated composite measure of morbidity [26] and the restriction of the population to a homogenous group of low-risk women receiving small volumes of blood. We did not consider the age of blood as a confounder, as it has not been shown to increase adverse outcomes in obstetric [50] and other populations [51] . This is an observational study and as such transfusion was given based on clinical judgement, not randomly allocated. Although a large range of clinical and maternal characteristics were adjusted for within a restricted low-risk population, and the possible effect of anaemia on morbidity was assessed, there remains the possibility that another unmeasured confounder may be responsible for the observed association of transfusion with adverse outcomes. A limitation of the data is that information was not available on the timing of the transfusion, or estimated blood loss; however, the study population was restricted to women receiving small volume transfusions, without other blood products, making it likely the transfusion was given in the absence of massive bleeding. The small number of women receiving single unit transfusions precluded a sensitivity analysis on this group. Despite limiting the study population to low-risk women having small volume transfusions and using propensity score analysis to match women, it may be that some of the identified morbidity is related to the amount of blood lost rather than the transfusion itself. The decision to transfuse involves a trade-off between the concern for a mother's ability to care for a new baby and concerns about adverse effects of the transfusion [52] . Treatment of anaemia in these women may improve well-being in the short term [53] , however, must be weighed against the risks associated with transfusion. Although the risk of transfusion transmitted infections and reactions is low [54] , this study suggests that even in a low-risk population, transfusion is associated with increased morbidity and healthcare use. While our findings support restrictive use of transfusion in obstetrics, we cannot rule out that at least some of the adverse outcomes demonstrated may be driven by the indication for transfusion, rather than the transfusion itself. Increased risks of readmission, even among lowrisk women experiencing haemorrhage suggest the need for ongoing monitoring in and beyond the postpartum period.
